Lanean...
Leucine-Rich Repeat Kinase 2 (LRRK2): A Key Player in the Pathogenesis of Parkinson’s Disease
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder with a prevalence of more than 1% after the age of 65 years. Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) have recently been linked to autosomal dominant, late-onset PD that is clinically indisting...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2009
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4072732/ https://ncbi.nlm.nih.gov/pubmed/19025767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jnr.21949 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|